[Prostate cancer mortality trends in Chile (1955-2019)].

IF 0.5 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
J Francisco López, Mario I Fernández, Fernando Coz
{"title":"[Prostate cancer mortality trends in Chile (1955-2019)].","authors":"J Francisco López,&nbsp;Mario I Fernández,&nbsp;Fernando Coz","doi":"10.4067/S0034-98872022001001370","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer is the tumor with the highest incidence among men and one of Chile's leading causes of death.</p><p><strong>Aim: </strong>To analyze temporal trends in prostate cancer mortality in Chile.</p><p><strong>Material and methods: </strong>Mortality rates in Chile for the period between 1955 and 2019 were calculated. The number of deaths was obtained from the national demographic yearbooks and the Ministery of Health mortality registries. Population estimates from the demographic center of the Economic Commission for Latin America and the Caribbean of the United Nations were used. Chilean census population of 2017 was used as reference to calculate adjusted rates. Trends were analyzed using a join point regression.</p><p><strong>Results: </strong>Crude mortality rates of prostatic cancer increased between 1995 and 2012 in three different phases, namely between 1955 and 1989 with a 2.7% annual increase, between 1989 and 1996 at a 6.8% annual rate, and between 1996 to 2012 with a 2.8% annual increase. From 2012 the rate remained stable. Adjusted mortality rates increased slowly at a 1.7% rate from 1955 to 1993, accelerating between 1993 and 1996, when they increased 12.1% per year. From 1996 onwards there was a significant decrease in mortality at a 1.2% annual rate. This decrease was significant and observed within all age groups but more importantly at older ages.</p><p><strong>Conclusions: </strong>Prostate cancer mortality in Chile has decreased significantly during the last two decades, like that observed in developed nations.</p>","PeriodicalId":21360,"journal":{"name":"Revista medica de Chile","volume":"150 10","pages":"1370-1379"},"PeriodicalIF":0.5000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Chile","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4067/S0034-98872022001001370","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prostate cancer is the tumor with the highest incidence among men and one of Chile's leading causes of death.

Aim: To analyze temporal trends in prostate cancer mortality in Chile.

Material and methods: Mortality rates in Chile for the period between 1955 and 2019 were calculated. The number of deaths was obtained from the national demographic yearbooks and the Ministery of Health mortality registries. Population estimates from the demographic center of the Economic Commission for Latin America and the Caribbean of the United Nations were used. Chilean census population of 2017 was used as reference to calculate adjusted rates. Trends were analyzed using a join point regression.

Results: Crude mortality rates of prostatic cancer increased between 1995 and 2012 in three different phases, namely between 1955 and 1989 with a 2.7% annual increase, between 1989 and 1996 at a 6.8% annual rate, and between 1996 to 2012 with a 2.8% annual increase. From 2012 the rate remained stable. Adjusted mortality rates increased slowly at a 1.7% rate from 1955 to 1993, accelerating between 1993 and 1996, when they increased 12.1% per year. From 1996 onwards there was a significant decrease in mortality at a 1.2% annual rate. This decrease was significant and observed within all age groups but more importantly at older ages.

Conclusions: Prostate cancer mortality in Chile has decreased significantly during the last two decades, like that observed in developed nations.

[智利前列腺癌死亡率趋势(1955-2019)]。
背景:前列腺癌是男性发病率最高的肿瘤,也是智利的主要死亡原因之一。目的:分析智利前列腺癌死亡率的时间趋势。材料和方法:计算了智利1955年至2019年期间的死亡率。死亡人数来自国家人口年鉴和卫生部死亡率登记处。使用了联合国拉丁美洲和加勒比经济委员会人口中心的人口估计数。以2017年智利人口普查为参考,计算调整后的比率。使用连接点回归分析趋势。结果:1995 - 2012年前列腺癌粗死亡率呈3个不同阶段增长,即1955 - 1989年年均增长2.7%,1989 - 1996年年均增长6.8%,1996 - 2012年年均增长2.8%。从2012年开始,这一比率保持稳定。调整后的死亡率从1955年至1993年以1.7%的速度缓慢增长,1993年至1996年期间加速,每年增长12.1%。从1996年起,死亡率以每年1.2%的速度显著下降。这种下降在所有年龄组中都很明显,但在老年人中更为重要。结论:在过去二十年中,智利的前列腺癌死亡率显著下降,与发达国家的情况类似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista medica de Chile
Revista medica de Chile 医学-医学:内科
CiteScore
1.20
自引率
16.70%
发文量
75
审稿时长
3-6 weeks
期刊介绍: La Revista Médica de Chile publica trabajos originales sobre temas de interés médico y de Ciencias Biomédicas, dando preferencia a los relacionados con la Medicina Interna y sus especialidades derivadas. Publicada mensualmente, desde 1872, por la Sociedad Médica de Santiago. La abreviatura de su título es Rev Med Chile, que debe ser usado en bibliografías, notas al pié de página, leyendas y referencias bibliográficas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信